ArticleBMJ open2025
Implementation of harm reduction services for people who use drugs provided by pharmacy staff: a scoping review protocol.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe disparities and risk trajectories experienced by people who use drugs (PWUD) highlight the critical need for equity-oriented strategies. Pharmacy staff (pharmacists, pharmacy technicians and assistants) make essential contributions to public health, and their role in the response to the drug overdose crisis can be understood as an extension of their public health role. Their involvement in overdose prevention strategies, such as take-home naloxone programmes and prescribed opioid medication management, has been documented. Still, their role in harm reduction services for PWUD has yet to be mapped. This gap has led to challenges when implementing harm reduction services in pharmacy-related settings. This review aims to summarise literature that focuses on the implementation of harm reduction services for PWUD provided by pharmacy staff. METHODS AND ANALYSIS: This scoping review will adhere to the Arksey and O'Malley framework for conducting scoping reviews. The electronic databases MEDLINE, Embase, CINAHL, Web of Science Core Collection, SCOPUS and Google Scholar were searched on 4 June 2024, using terms related to pharmacy staff, PWUD and harm reduction services. This review will consider peer-reviewed literature in English, Spanish and French focused on describing or evaluating the implementation of harm reduction services for PWUD by pharmacy staff. Two independent reviewers will screen titles and abstracts and conduct the full-text screening to determine eligibility. Findings will be presented as a narrative summary and supported by tabular and graphical formats. Knowledge partner engagement will guide all steps in this study. ETHICS AND DISSEMINATION: Formal ethical approval is not required, as primary human or animal data will not be collected. A manuscript summarising the results will be written and submitted to a peer-reviewed journal for publication. Other outlets for dissemination will include local presentations and conference presentations. TRIAL REGISTRATION DETAILS: Open Science Framework (https://osf.io/vn6ht).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.